Phase I dose escalation study of nivolumab (Anti-PD-1; BMS-936558; ONO-4538) in patients (pts) with advanced hepatocellular carcinoma (HCC) with or without chronic viral hepatitis.
暂无分享,去创建一个
J. Prieto | B. Sangro | T. Crocenzi | T. Welling | Jeffrey Anderson | I. Melero | W. Feely | J. Wigginton | A. Gupta | D. Grasela | M. Iñarrairaegui | Carmen Fuertes | Laurie Delanty | J. Prieto | Carmen Fuertes